ECSP992845A - CHEMICAL COMPOUNDS - Google Patents

CHEMICAL COMPOUNDS

Info

Publication number
ECSP992845A
ECSP992845A ECSP992845A ECSP992845A EC SP992845 A ECSP992845 A EC SP992845A EC SP992845 A ECSP992845 A EC SP992845A EC SP992845 A ECSP992845 A EC SP992845A
Authority
EC
Ecuador
Prior art keywords
chemical compounds
carbon atoms
alkoxy
halogen
atoms
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Alan Naylor
Ian P Campbell
Paul John Beswick
Neil Mathews
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992845 priority Critical patent/ECSP992845A/en
Publication of ECSP992845A publication Critical patent/ECSP992845A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención proporciona los compuestos de fórmula (I) y derivados del mismo, farmacéuticamente aceptables en los cuales: R0 es halógeno, alquilo de 1 a 6 átomos de carbono, alcoxi de 1a átomos de carbono, alcoxi de 1 a 6 átomos de carbono sustituido por uno o más átomos de flúor, o (CH2)n NR455.The invention provides the pharmaceutically acceptable compounds of formula (I) and derivatives thereof in which: R0 is halogen, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to carbon atoms, alkoxy of 1 to 6 substituted carbon atoms by one or more fluorine atoms, or (CH2) n NR455.

ECSP992845 1999-02-02 1999-02-02 CHEMICAL COMPOUNDS ECSP992845A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992845 ECSP992845A (en) 1999-02-02 1999-02-02 CHEMICAL COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992845 ECSP992845A (en) 1999-02-02 1999-02-02 CHEMICAL COMPOUNDS

Publications (1)

Publication Number Publication Date
ECSP992845A true ECSP992845A (en) 1999-05-17

Family

ID=42043835

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992845 ECSP992845A (en) 1999-02-02 1999-02-02 CHEMICAL COMPOUNDS

Country Status (1)

Country Link
EC (1) ECSP992845A (en)

Similar Documents

Publication Publication Date Title
EA200300717A1 (en) Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands
DK1382604T3 (en) Quinoline derivatives with an azolyl group and quinazoline derivatives
AR021055A1 (en) PIRAZOLOPIRIDINE DERIVATIVES
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
IS6565A (en) The tropane derivatives are useful in the treatment
EA200201179A1 (en) DERIVATIVES 2-AMINOKARBONIL-9H-PURINA
ATE302775T1 (en) CARBOLINE DERIVATIVES
EA200301142A1 (en) DERIVATIVES OF HETEROCYCLILOXY-, -TIOOXY-AND-AMINOBENZAZOL AS A LYHANDS OF 5-HYDROXITRIPTAMINE-6
ATE380818T1 (en) PIPERAZINE-SUBSTITUTED ARYL-BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOSIS
EA200300716A1 (en) HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6
ATE231149T1 (en) (1,8)-NAPHTHYRIDINE DERIVATIVES DERIVATIVES WITH ANTIVIRAL EFFECT
ATE300543T1 (en) CONDENSED PYRAZINEDIONE DERIVATIVES AS PDE5 INHIBITERS
ATE346067T1 (en) CARBOLINE DERIVATIVES
DE60336735D1 (en) NEW BIOLOGICAL MOLEKÜ LE
NO20050871L (en) 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
ATE210649T1 (en) ARYLACRYLAMIDE DERIVATIVES AS 5HT1 AGONISTS OR ANTAGONISTS
RS50229B (en) Vitamin d3 analogs
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
ATE333457T1 (en) CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS
ES2188134T3 (en) CICLOHEXANDIOL DERIVATIVES.
BRPI0416678A (en) pyrazolpyrimidines
DK1021421T3 (en) Amino- and hydroxy-substituted triphenyl-S-triazines as stabilizers
ATE239722T1 (en) BENZOFURYLPIPERAZINE AS SEROTONIN AGONISTS
NO20022977L (en) Substituted homopiperidinylbenzimidazole analogs as fundamental relaxants
ATE293111T1 (en) CONDENSED PYRAZINEDIONE DERIVATIVES AS PDE INHIBITORS